<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Interacting Drug </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">
<content stylecode="bold">Interaction </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Antacids, sucralfate, multivitamins, and other products containing multivalent cations <br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Moxifloxacin absorption is decreased. Administer moxifloxacin hydrochloride tablet at least 4 hours before or 8 hours after these products. (<linkhtml href="#Section_2.2">2.2</linkhtml>, <linkhtml href="#Section_7.1">7.1</linkhtml>, <linkhtml href="#Section_12.3">12.3</linkhtml>, <linkhtml href="#Section_17">17</linkhtml>) <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Warfarin <br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Anticoagulant effect of warfarin may be enhanced. Monitor prothrombin time/INR, watch for bleeding. (<linkhtml href="#Section_6.4">6.4</linkhtml>, <linkhtml href="#Section_7.2">7.2</linkhtml>, <linkhtml href="#Section_12.3">12.3</linkhtml>) <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Class IA and Class III antiarrhythmics: <br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Proarrhythmic effect may be enhanced. Avoid concomitant use. (<linkhtml href="#Section_5.3">5.3</linkhtml>, <linkhtml href="#Section_7.5">7.5</linkhtml>) <br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">Antidiabetic agents<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Carefully monitor blood glucose (<linkhtml href="#Section_5.10">5.10</linkhtml>, <linkhtml href="#Section_7.3">7.3</linkhtml>)<br/>
</td>
</tr>
</tbody>
</table>